72 Million American Women Have Skipped or Delayed Vital Screenings
2024年7月9日 - 5:05PM
ビジネスワイヤ(英語)
New Survey Reveals Women Struggle to Prioritize
Their Health
Millions of women in the United States have missed screenings
for serious, often life-threatening conditions, according to a new
survey released today by women’s health innovator Hologic, Inc.
(Nasdaq: HOLX).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240709118503/en/
Hologic Global Women's Health Index -
United States Data Report (Graphic: Business Wire)
The nationally representative study, commissioned by Hologic and
conducted by Gallup, reveals a vast “Screening Action Gap.”
Although women overwhelmingly say regular health screenings are
important, an estimated 72 million have skipped or delayed a
recommended screening. These missed screenings include those for
significant health conditions like breast, cervical and colorectal
cancers, which together kill more than 70,000 U.S. women each
year.
The survey asked 4,001 women about their experiences and
perspectives on health. It builds on the annual Hologic Global
Women’s Health Index, which captures the views of women and girls
from more than 140 countries.
“We choose to put energy and resources behind the Global Women’s
Health Index because you can only improve what’s measured,” said
Stephen P. MacMillan, Chairman, President and CEO of Hologic. “This
survey, our first-ever focused on the U.S., reveals so much about
the challenges women face when prioritizing their health. It’s
sobering to think that 72 million American women miss life-changing
screenings because of cost, anxiety and prior negative experiences.
Our hope is that this survey will be the impetus for more screening
awareness, education and policy.”
Key findings of the U.S. survey
include:
- The Screening Action Gap: While 90% of women recognize
the importance of regular health screenings, more than 40% have
skipped or delayed a recommended test.
- Women are most likely to have skipped screenings for breast
(41%), cervical (35%) and colorectal (33%) cancers.
- Women’s main reasons for skipping or delaying a recommended
screening include not knowing the screening was necessary or
important for them (24%), anxiety about tests (20%), lack of time
(20%) or concerns about pain or discomfort (17%).
- Compared to women of other races, Black women were much more
likely to say screenings are very important to them — and much less
likely to say they have skipped or delayed a screening.
- Drivers of the Screening Action Gap:
- Lack of information: Only about 4 in 10 women say they
are “very confident” in knowing which screenings they need based on
their age and risk factors. More broadly, many women — including 3
in 10 adult Gen Z women and just under 1 in 4 Millennials — say
it’s hard for them to find the health information they need.
- Lack of communication with healthcare professionals:
Women who discuss screenings with healthcare professionals are more
likely to get screened. However, these crucial conversations about
screenings often do not occur. For example, among women ages 35 and
over — the recommended age group for skin cancer screening — only
about half said they have spoken to a healthcare professional about
getting screened for skin cancer, and even fewer have been
screened.
- Emotional health: More than 6 in 10 women, including 75%
of women with children in their home, say it is hard to make their
health a top priority. Among these women, the top two barriers are
feeling overwhelmed (72%) and emotional health (60%).
To see the full survey and related resources, visit
WomensHealthIndex.com/Hologic-US-Health-Survey.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused
on improving the health and well-being of women, their families and
communities through early detection and treatment. Its advancements
include invention of the world’s first commercial 3D mammography
system to find breast cancer earlier; leadership in testing for
cervical cancer, sexually transmitted infections and respiratory
illnesses; and minimally invasive surgical technologies for uterine
fibroids and abnormal uterine bleeding. The company also champions
women through the Hologic Global Women’s Health Index, which
provides a science-backed data framework for improving women’s
well-being.
For more information about the company, visit
www.Hologic.com.
Hologic and The Science of Sure are trademarks and/or registered
trademarks of Hologic, Inc. and/or its subsidiaries in the United
States and/or other countries.
About Gallup
Gallup delivers analytics and advice to help leaders and
organizations solve their most pressing problems. Combining more
than 80 years of experience with its global reach, Gallup knows
more about the attitudes and behaviors of employees, customers,
students and citizens than any other organization in the world.
SOURCE: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240709118503/en/
Media Contact Bridget Perry Director, Corporate
Communications (+1) 508.263.8654 bridget.perry@hologic.com
Investor Contact Ryan Simon Vice President, Investor
Relations (+1) 858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
過去 株価チャート
から 6 2024 まで 7 2024
Hologic (NASDAQ:HOLX)
過去 株価チャート
から 7 2023 まで 7 2024